Financhill
Back

Petros Pharmaceuticals Stock Predictions

Petros Pharmaceuticals Stock Forecast

  • Is Petros Pharmaceuticals Stock Undervalued?
    The current Petros Pharmaceuticals [PTPI] share price is $0.03. The Score for PTPI is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • PTPI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Petros Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Petros Pharmaceuticals Stock Rating

Data Unavailable

Petros Pharmaceuticals Stock Price History

Is PTPI stock going to rise?

  • The current trend is relatively stagnant and PTPI is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
petrospharma.com

52-Week Data

52-Week High:
16.25
52-Week Low:
0.02

Prediction Charts

Market Cap:
1.7M
Price in USD:
0.03
Volume:
342.8K
Beta:
41.85

Technical Analysis

SMA50:
0.51
SMA100:
2.29
SMA200:
5.35
52-Wk Change:
-99.73%

Stock Predictions

  • Is Petros Pharmaceuticals stock public?
    Yes, Petros Pharmaceuticals is a publicly traded company.
  • What is the Petros Pharmaceuticals stock quote today?
    The Petros Pharmaceuticals stock price is 0.03 USD today.
  • How to buy Petros Pharmaceuticals stock online?
    You can buy Petros Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-27 0.03 0.03 0.04 0.03
May-28 0.03 0.04 0.04 0.03
May-29 0.04 0.03 0.04 0.03
May-30 0.04 0.04 0.04 0.03
Jun-2 0.04 0.03 0.04 0.03
Jun-3 0.03 0.03 0.04 0.03
Jun-4 0.04 0.03 0.04 0.03
Jun-5 0.03 0.03 0.03 0.03
Jun-6 0.03 0.03 0.04 0.03
Jun-9 0.03 0.03 0.04 0.03
Jun-10 0.03 0.03 0.03 0.03
Jun-11 0.03 0.03 0.03 0.03
Jun-12 0.03 0.03 0.03 0.03
Jun-13 0.03 0.03 0.03 0.03

Petros Pharmaceuticals Earnings

Data Unavailable

Petros Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and a decrease next year of $0.00 per share.

* Petros Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.